Blog

Explore the breakthrough discovery and clinical success of daraxonrasib (RMC-6236), a first-in-class, oral RAS(ON) multi-selective inhibitor. This technical deep-dive covers the medicinal chemistry journey from macrocyclic scaffolds to the landmark RASolute 302 Phase 3 results in metastatic PDAC. Learn how the shift from "off-state" targeting to active-state tri-complex inhibition is transforming the treatment landscape for RAS-addicted cancers.

Explore GLP-1 receptor agonists, their mechanisms, and the chemistry behind weight loss drugs. A practical guide to molecular building blocks for drug discovery.

Discover how terminal alkynes drive modern drug discovery. Learn their unique sp-hybridized electronic structure, CuAAC click chemistry mechanism, DMPK optimization, PROTAC linker design, and covalent warhead strategies. AiFChem offers 12,500+ high-purity terminal alkynes with XtalPi-validated synthesizability.

While inorganic systems have long dominated energy storage, organic materials are emerging as a commercial necessity for next-generation batteries. This article examines the integration of organic chemistry across all five core cell components: electrodes, current collectors, binders, electrolytes, and separators. By utilizing tunable molecular structures and sustainable precursors, organic materials offer unique "chemical flexibility".

Discover AiFCHem’s novel molecular building blocks designed to overcome T790M and C797S resistance mutations in EGFR inhibitors. These unique scaffolds deliver new hydrogen-bonding patterns, metabolic stability, and patentable chemical space for next-generation NSCLC targeted therapies.

In 2025, FDA approved 46 novel drugs. Explore how AI-driven drug discovery, AlphaFold3, CRISPR gene editing, and regulatory innovations are accelerating precision medicine. Discover how AiFChem’s 1.2M+ molecular building blocks help researchers speed up hit-to-lead optimization.

Discover the latest breakthroughs in drug discovery as of March 2026: FDA’s record 55-day approval, rucaparib for prostate cancer, AI-driven candidates in clinical trials, and how AiFChem’s 1.2+ million high-quality molecular building blocks and vast chemical space empower faster lead optimization.

Bicyclo[1.1.1]pentane (BCP) has emerged as a powerful three-dimensional bioisostere for benzene, addressing long-standing challenges associated with flat, aromatic scaffolds in drug design. This article explores the scientific rationale behind BCP, key breakthroughs that enabled its adoption, recent advances in synthetic accessibility, and its growing impact across pharmaceutical research. As the field continues to prioritize molecular complexity and developability, BCP stands out as a compelling alternative shaping the future of medicinal chemistry.

Discover click chemistry reagents including CuAAC and SPAAC. Learn their types, key applications in drug discovery, bioconjugation, materials science, and the latest bioorthogonal advances in 2025.

1,2,3-Triazoles are nitrogen-rich five-membered rings that have become indispensable in modern drug discovery. Formed efficiently via CuAAC Click Chemistry, they serve as robust amide bioisosteres, enabling the design of antibacterial, anticancer, and kinase inhibitor candidates with high metabolic stability, tunable pharmacology, and precise 3D target engagement.